Concepedia

Karma Dacosta

KD

10

Publications

391

Citations

10

H-Index

2016

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AstraZeneca (United States)

NGM Biopharmaceuticals (United States)

Karma Dacosta is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, medicine, and tumor immunology.

ORCID

Top concepts

Publications per year

2016–2022

10

Publications

10

T follicular helper–like cells contribute to skin fibrosis

Devon K. Taylor, Nanette Mittereder, Ellen Kuta et al. · Science Translational Medicine · 2018 · 102 citations

Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis

Keith E. Steele, Tze Heng Tan, R Korn et al. · Journal for ImmunoTherapy of Cancer · 2018 · 98 citations · Full text

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer

Song Cho, Francesca Zammarchi, David G. Williams et al. · Molecular Cancer Therapeutics · 2018 · 46 citations

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Michael Surace, Karma Dacosta, Anna Huntley et al. · Journal of Visualized Experiments · 2019 · 37 citations

Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice

Nanette Mittereder, Ellen Kuta, Geetha Bhat et al. · The Journal of Immunology · 2016 · 26 citations · Full text

Rows per page

1–5 of 10